Adaptive Biotechnologies Corp — Director's Dealing 2020

May 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-05-19

Reporting Person: BENZENO SHARON (Chief Business Development Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-19	Common Stock	M	60000	$1.98	Acquired	60000	Direct
2020-05-19	Common Stock	M	18750	$6.32	Acquired	78750	Direct
2020-05-19	Common Stock	M	15416	$6.27	Acquired	94166	Direct
2020-05-19	Common Stock	M	78125	$6.55	Acquired	172291	Direct
2020-05-19	Common Stock	M	49479	$6.55	Acquired	221770	Direct
2020-05-19	Common Stock	M	25000	$7.27	Acquired	246770	Direct
2020-05-19	Common Stock	S	246770	$40.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-19	Stock Option (Right to Buy)	$1.98	M	60000	Disposed	2024-04-13	Common Stock (60000)	Direct
2020-05-19	Stock Option (Right to Buy)	$6.32	M	18750	Disposed	2026-09-16	Common Stock (18750)	Direct
2020-05-19	Stock Option (Right to Buy)	$6.27	M	15416	Disposed	2027-04-25	Common Stock (15416)	Direct
2020-05-19	Stock Option (Right to Buy)	$6.55	M	78125	Disposed	2028-02-07	Common Stock (78125)	Direct
2020-05-19	Stock Option (Right to Buy)	$6.55	M	49479	Disposed	2028-10-01	Common Stock (49479)	Direct
2020-05-19	Common Stock (Right to Buy)	$7.27	M	25000	Disposed	2029-02-07	Common Stock (25000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020.

F2: The option is vested and fully exercisable.

F3: The options vested with respect to 1/4 of such shares on July 26, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F4: The options vested with respect to 1/4 of such shares on April 19, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F5: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F6: The options vested with respect to 1/4 of such shares on October 1, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F7: The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.